Catastrophic healthcare expenditure and coping strategies among patients attending cancer treatment services in Addis Ababa, Ethiopia

Table 2 Clinical information of patients attending cancer treatment services in Addis Ababa, Ethiopia 2018

Clinical variables	N	% (95% CI)
Type of cancer
Breast cancer	130	36.9 (32.0–42.1)
Cervical cancer	58	16.5 (13.0–20.7)
Colorectal cancer	46	13.1 (9.9–17.0)
NPC^a	13	3.7 (2.2–6.3)
Others^b	105	29.8 (25.3–35.0)
Type of treatments taken^c
Supportive treatment	352	100.0
Chemotherapy	313	89.0 (85.2–91.8)
Surgery	201	57.1 (51.8–62.2)
Radiotherapy	176	50.0 (44.8–55.2)
Hormonal	80	22.7 (18.6–27.4)
Cycle of treatment taken
4–6 cycles	155	44.0 (38.9–49.3)
1–3 cycles	97	27.6 (23.1–32.5)
> 6 cycles	61	17.3 (13.7–21.7)
On other treatment options	39	11.1 (8.2–14.8)
Private health facility visit history
Yes	223	63.4 (58.2–68.2)
No	129	36.6 (31.8–41.8)

^a: NPC Nasopharyngeal cancer,
^b: Other cancer types (including skin, oral, lung, liver, esophageal, bone, Hodgkin lymphoma, non-Hodgkin lymphoma, thyroid and other unspecified tumors, confirmed on histological and/or pathologically exam)
^C: Frequencies and percentage will not be added up because multiple responses were possible

ISSN: 1471-2458